Magnesium Supplementation for Sleep Improvement in Adults
Magnesium 250 mg
Autre étude
Résumé
Date de début de l'étude : 15 février 2023
Date à laquelle le premier participant a commencé l'étude.This study focuses on improving sleep health through the use of magnesium supplements. It involves 60 participants who experience sleep issues. The goal is to understand if magnesium can enhance sleep quality, addressing the need for better sleep solutions. Participants are required to consume a daily magnesium supplement of 250mg over a period of 56 days. During the study, participants visit a Sleep Lab three times. The first visit involves receiving an actiwatch, a device that monitors sleep patterns for seven nights. On the second visit, participants return the actiwatch, receive a new one, and get their magnesium supplement. They also complete a diet recall and a gastrointestinal symptoms questionnaire. The final visit includes returning the actiwatch and any leftover supplements, followed by a debriefing. The study measures sleep efficiency, sleep onset latency, total sleep time, and wake after sleep onset using actigraphy. It also evaluates dietary habits, gastrointestinal symptoms, anxiety levels, and depression symptoms through various questionnaires.
Protocole
Cette section fournit des détails sur le plan de l'étude, y compris la manière dont l'étude est conçue et ce qu'elle évalue.65 participants à inclure
Nombre total de participants que l'essai clinique vise à recruter.Autre
Éligibilité
Les chercheurs recherchent des patients correspondant à une certaine description appelée critères d'éligibilité : état de santé général ou traitements antérieurs du patient.Tout sexe
Le sexe biologique des participants éligibles à s'inscrire.De 18 à 39 ans
Tranche d'âge des participants éligibles à participer.Volontaires sains autorisés
Indique si les individus en bonne santé et ne présentant pas la condition étudiée peuvent participer.Critères
Inclusion Criteria: * Healthy male or female adult between the ages of 18 and 39 years of age. * Have a stable sleep/wake schedule (bedtime between 9pm and 1am and wake time between 6am and 10am at least 5 nights per week) * Are a fluent English speaker * Diet which is low in magnesium * Self-identify as a poor sleeper (i.e. poor sleep quality or unrefreshing sleep). Exclusion Criteria: * Have symptoms of COVID-19 * Display evidence of current or recent sleep disorders (e.g. sleep apnea, insomnia, circadian rhythm disorders); an initial screening for sleep disorders will be conducted using the Sleep Disorders Screening Checklist - 25 (SDS-CL). Have a history of seizures or epilepsy * Have recently (within the last 12 weeks) had an infection and/or used antibiotic medication * Are pregnant, seeking to become pregnant or lactating * Are a shift worker or a recent history of shift work in the previous 6 months * Are participating in other intervention research trials * Have experienced travel across multiple time zones within the last three months or will be experiencing travel across multiple time zones during the study. * Have recently been diagnosed and/or treated for a mental health or substance use disorder. * Are currently unwell with anything that impacts sleep. * Are taking any medication which has a sedative effect * Are currently using medication which affects the central nervous system. * Are currently misusing alcohol or drugs.
Plan de l'étude
Découvrez tous les traitements administrés dans cette étude, leur description détaillée et ce qu'ils impliquent.Un seul groupe d'intervention est désigné dans cette étude
Cette étude ne comporte pas de groupe placebo.
Groupes de traitement
Groupe I
ExpérimentalCentres d'étude
Ce sont les hôpitaux, cliniques ou centres de recherche où l'essai est conduit. Vous pouvez trouver le site le plus proche de vous ainsi que son statut.Cette étude comporte 1 site
Northumbria Sleep Research, Northumbria University
Newcastle, United KingdomOuvrir Northumbria Sleep Research, Northumbria University dans Google Maps